➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Dow
Colorcon
Boehringer Ingelheim
Johnson and Johnson

Last Updated: June 12, 2021

DrugPatentWatch Database Preview

Litigation Details for ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2016)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patents cited in this case is   Get Started Free .

Details for ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2016)

Date Filed Document No. Description Snippet Link To Document
2018-11-07 128 Construction and Prehearing Statement for U.S. Patent No. 9,775,838 by ADAPT PHARMA LIMITED, ADAPT PHARMA OPERATIONS…October 2016 2:16-cv-07721-BRM-JAD 830 Patent None District Court, D. New Jersey External link to document
2019-02-07 171 Amended Invalidity Contentions for U.S. Patent Nos. 9,211,253; 9,68,747; 9,561,177;9,629,965; and 9,775,838…October 2016 2:16-cv-07721-BRM-JAD 830 Patent None District Court, D. New Jersey External link to document
2019-04-24 200 of United States Patent Numbers 9,211,253 (“‘253 patent”) and 9,468,747 (“747 patent”), Claim 10 of the… ‘253 patent and ‘747 patent, and Claim 29 of United States Patent No. 9,629,965 (“‘965 patent”).’ The…the ‘253 patent, Claims 3 and 33 of the ‘747 patent, Claims 5 and 27 of United States Patent No. 9,561,177…actuation.” (‘253 patent at 50:65—67; ‘747 patent at 53:42—44). Elsewhere, the ‘253 patent specification …9,561,177 (“177 patent”), and Claims 1 and 22 of the ‘965 patent. They have since resolved their dispute External link to document
2019-04-24 201 about 100 ul" as used in United States Patent Numbers 9,211,253 and 9,468,747 requires no further construction…October 2016 2:16-cv-07721-BRM-JAD 830 Patent None District Court, D. New Jersey External link to document
2019-11-13 283 Brief longer-asserted U.S. Patent No. 9,211,253 (“the 253 patent”).1 For each patent, Nalox-1 filed one petition…Challenged Patent Prior Art Instituted? IPR2019-00685 9,211,2539,211,253 Wang No IPR2019-00687 9,211,253 …administrative patent judges is tasked with reviewing the patentability of a previously issued patent. To request… the four patents-in- suit before this Court (U.S. Patent Nos. 9,468,747 (“the ’747 patent”), 9,561, External link to document
2020-06-05 342 Order States Patents held by Plaintiffs: (1) Claims 7 and 9 of United States Patent Number 9,468,747 (the …the “’747 Patent”) (TX-0001) 2; (2) Claim 4 of United States Patent Number 9,561,177 (the “’177 Patent…, 24, and 25 of United States Patent Number 9,629,965 (the “’965 Patent”) (TX-0003); and (4) Claims…, 33, and 38 of United States Patent Number 9,775,838 (the “’838 Patent) (TX-0004). 1 On… ’747 Patent are INVALID; and it is further ORDERED that Claim 4 of the ’177 Patent is INVALID External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Moodys
Express Scripts
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.